Immuron
Immuron focuses on oral immunotherapy using polyclonal antibody products for humans.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Immuron Information
Geographic Data
Address:
City: Armadale
State: Victoria
Zip:
Country: Australia
Financial Info
Stage:
grant
Raised Last:
$3M
Raised Total:$28M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Immuron Ltd is a publicly listed Australian bio pharmaceutical Microbiome company focused on oral immunotherapy using polyclonal antibody products for humans. Immuron is a uniquely positioned company developing therapeutic products in NASH, ASH and other diseases mediated through gut disbiosis.
Contact Phone:
Contact Email:
Immuron went public on 4/18/2017 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/18/2017
Ticker Symbol:
IMRN
IPO Price:
$10/share
Amount Raised:
$6M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 10/2022 | Ateria Health | Corporate Round | 0 |
| 10/2022 | Ateria Health | Corporate Round | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2022 | Grant | 1 | $3.5M |
U.S. Department of Defense U.S. Department of Defense U.S. Department of Defense U.S. Department of Defense |
3/2018 | Post-IPO Equity | $4M | 7/2020 | Post-IPO Equity | $20M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
